AIM

AIM ImmunoTech

14 hedge funds and large institutions have $2.09M invested in AIM ImmunoTech in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$76K
2 +$61.4K
3 +$25K

Top Sellers

1 -$30K
2 -$25.2K
3 -$13.6K
4
Goldman Sachs
Goldman Sachs
New York
-$5K
5
CS
Credit Suisse
Switzerland
-$4K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$856K
2
$522K
3
$189K
4
$133K
5
$86K
6
$76K
7
$68K
8
$57K
9
$25K
10
$21K
11
$15K
12
$13K
13
$7K
14
$7K
15
$5K
16
$3K
17
$2K
18
$2K
19
$2K
20
21
22
23